跳至主要内容
临床试验/NCT07505797
NCT07505797招募中不适用

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE), a Case Collection Registry for 3D Breast Automated Ultrasound Using ATUSA System as Well as Other Breast Imaging Modalities.

iSono Health, Inc.2 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2025年12月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
800
试验地点
2
主要终点
Type and Number of breast imaging examinations collected per participant

研究概览

简要总结

AUDIBLE is a multi-site, clinical study conducted in the United States aimed at gathering data on 3D Automated Breast Ultrasound imaging using the iSono Health ATUSA system. The study focuses on female participants who have previously been identified with suspicious findings (classified as BIRADs 4 or 5) through standard-of-care diagnostic imaging methods (e.g., hand-held ultrasound, mammograms) and who have been referred for a biopsy. The goal is to create a comprehensive registry that includes multi-modality breast images alongside and biopsy results. The study will enroll up to 800 eligible female patients. In addition to imaging data, the study will collect information from the patient's medical records and biopsy outcomes.

The study aims to validate ATUSA's image quality, reproducibility, and correlation with histopathology and radiologist-assigned BI-RADS categories. Additionally, a subset of participants receiving neoadjuvant therapy will be followed longitudinally to evaluate ATUSA's potential for monitoring treatment response and volumetric changes in tumor burden.

This study supports the advancement of a patient-friendly, radiation-free, operator-independent ultrasound platform for real-time breast imaging.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 94 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Provide written informed consent through a signed and dated consent form.
  • Demonstrate commitment to complete all study requirements and maintain availability for the full study duration.
  • Be female, aged 18 to 94 years (inclusive).
  • Have a recent BI-RADS® 4 or 5 classification confirmed through breast imaging and medical records.

排除标准

  • Active skin lesions (open wounds or unhealed sores) on either breast.
  • Implanted medical devices (pacemakers, defibrillators) or MRI incompatible materials that cannot be temporarily removed.
  • Current pregnancy or breastfeeding status (self-reported).Documented hypersensitivity to silicone or gadolinium-based contrast agents.
  • Previous bilateral mastectomy.
  • Physical inability to maintain a supine position for 30 minutes.
  • Breast anatomy incompatible with ATUSA device specifications.
  • Recent (within 12 months) breast surgery or cancer treatment.
  • Negative findings on diagnostic ultrasound examination within 30 days of Screening, but prior to initiating study required procedures.
  • Any medical or psychological condition that, in the Principal Investigator's judgment, could affect study participation or data integrity.

结局指标

主要结局

Type and Number of breast imaging examinations collected per participant

时间窗: From Enrollment to +/- 180 days

The breast imaging exams (type and number) performed per patient (ATUSA, DBT, HHUS, MRI, and, if applicable, other exams such as FFDM) and number of biopsy-confirmed cancer cases.

次要结局

  • Overall Operator satisfaction as assessed by questionnaire(Day of ATUSA Imaging/Enrollment Visit (Day 0))
  • Participant satisfaction as assessed by questionnaire(Day of ATUSA Imaging/Enrollment Visit (Day 0))
  • Number of participants with adverse events related to the ATUSA system(Enrollment through 7 days follow-up period)

研究者

发起方
iSono Health, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验